Molbio Diagnostics IPO Subscription Status
Final figures at close of bidding: 17 Aug 2026, 6:30 pm IST
| Category | Subscription |
|---|---|
| QIB | 186.39x |
| NII | 49.8x |
| sNII (₹2L–₹10L) | 47.76x |
| bNII (above ₹10L) | 50.82x |
| Retail (RII) | 12.97x |
| Employee | 13.28x |
| Total | 70.27x |
Bidding day 3
Day-wise subscription
| Day | QIB | sNII | bNII | Retail | Employee | Total |
|---|---|---|---|---|---|---|
| Day 1 | 1x | 0.8x | 0.7x | 0.77x | 2.12x | 0.83x |
| Day 2 | 1.39x | 7.02x | 4.31x | 3.19x | 4.79x | 2.95x |
| Day 3 | 186.39x | 47.76x | 50.82x | 12.97x | 13.28x | 70.27x |
Times subscribed per category (bids vs shares offered, anchor portion excluded). Bidding has closed — these are the final figures.
How the book filled
Day-by-day demand
Demand in the Molbio Diagnostics IPO accumulated over 3 days of bidding: overall subscription stood at 0.83× at the close of day 1, read 2.95× at the end of day 2, and finished at 70.27× on day 3. On the final day it was qualified institutional buyers (QIB) driving the book, at 186.39× of the shares set aside for the category. More than half of the final demand arrived after day 1 — a late-building book. The largest single-day addition came on day 3, when the overall multiple moved from 2.95× to 70.27×.
Category detail
The QIB portion ended at 186.39×. Non-institutional investors came in at 49.8×, split 47.76× in the small-NII bucket (bids under ₹10 lakh) and 50.82× among big NIIs (above ₹10 lakh). Within the NII book, the bigger ₹10-lakh-plus bids outpaced the smaller applications. Retail investors put in bids for 12.97× the shares reserved for them. Reserved portions ended with the employee quota at 13.28×. That puts qualified institutional buyers (QIB) at the top of the book at 186.39× and retail investors at the bottom at 12.97×.
What the multiple means for allotment
Retail bids ran to about 12.97 times the shares earmarked for the category. When a retail book is oversubscribed, the registrar does not allot proportionately — allotment runs as a computerised lottery among all valid applications, with each successful application receiving at least one lot of 18 shares — ₹14,526 of stock at the upper band. The multiple above is the data point that determines how thinly that draw is spread; it describes the final book, not the outcome of any single application.
Frequently asked questions
- When does the Molbio Diagnostics IPO open and close?
- The Molbio Diagnostics IPO opens on 10 Aug 2026 and closes on 12 Aug 2026.
- How many times was the Molbio Diagnostics IPO subscribed?
- The Molbio Diagnostics IPO was subscribed 70.27 times in total across all investor categories.
- What is the reservation split in the Molbio Diagnostics IPO?
- Of the total shares offered, retail investors get 34.94%, QIBs 19.96% (plus 29.95% anchor), non-institutional investors 14.97%.